Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
37.25B | 37.77B | 35.55B | 33.06B | 31.95B | Gross Profit |
13.70B | 13.55B | 12.33B | 11.90B | 11.53B | EBIT |
1.07B | 830.47M | -245.54M | -255.18M | -1.61B | EBITDA |
2.73B | 2.34B | 1.59B | 2.06B | 1.50B | Net Income Common Stockholders |
884.95M | 405.11M | -28.17M | 232.60M | -273.42M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.62B | 1.14B | 1.22B | 1.19B | 1.15B | Total Assets |
43.51B | 43.52B | 42.48B | 42.14B | 42.36B | Total Debt |
495.05M | 2.98B | 6.84B | 6.56B | 6.42B | Net Debt |
-2.12B | 1.84B | 5.62B | 5.37B | 5.27B | Total Liabilities |
16.47B | 16.91B | 16.74B | 16.06B | 16.34B | Stockholders Equity |
27.04B | 26.61B | 25.74B | 26.08B | 26.02B |
Cash Flow | Free Cash Flow | |||
4.48B | 3.87B | -121.67M | -58.78M | -529.23M | Operating Cash Flow |
5.17B | 4.71B | 658.08M | 503.97M | -172.53M | Investing Cash Flow |
-653.75M | -109.96M | -605.15M | -250.12M | 596.21M | Financing Cash Flow |
-3.03B | -4.68B | -17.36M | -212.76M | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥19.64B | 7.39 | 0.49% | 7.49% | 97.16% | ||
76 Outperform | ¥21.74B | 20.71 | 4.39% | -1.95% | 13.15% | ||
75 Outperform | ¥24.21B | 12.88 | ― | 16.73% | 80.15% | ||
67 Neutral | ¥21.44B | 78.83 | 0.77% | 0.20% | 21.56% | ||
65 Neutral | $8.82B | 14.91 | 4.71% | 6.22% | 3.60% | -2.66% | |
65 Neutral | ¥23.74B | 37.73 | 2.04% | 0.93% | 330.14% | ||
62 Neutral | ¥18.36B | 20.19 | 2.11% | -1.38% | 120.33% |